论文期刊

取消

高级检索

检索历史清除

首页> Annals of surgical oncology> Phase I Trial of Hyperthermic Intraperitoneal Chemoperfusion (HIPEC) with Cisplatin, Mitomycin, and Paclitaxel in Patients with Gastric Adenocarcinoma and Associated Carcinomatosis or Positive Cytology.

Phase I Trial of Hyperthermic Intraperitoneal Chemoperfusion (HIPEC) with Cisplatin, Mitomycin, and Paclitaxel in Patients with Gastric Adenocarcinoma and Associated Carcinomatosis or Positive Cytology.

导出原文传递

翻译打印收藏纠错

第一作者： Mariela,Blum Murphy

第一单位： Departments of Gastrointestinal Medical Oncology, MD Anderson Cancer Center, Houston, TX, USA.

作者： Mariela,Blum Murphy ^[1] ; Naruhiko,Ikoma ^[2] ; Xuemei,Wang ^[3] ; Jeannelyn,Estrella ^[4] ; Sinchita,Roy-Chowdhuri ^[4] ; Prajnan,Das ^[5] ; Bruce D,Minsky ^[5] ; Shumei,Song ^[1] ; Paul,Mansfield ^[2] ; Jaffer,Ajani ^[1] ; Brian,Badgwell ^[6]

作者单位： Departments of Gastrointestinal Medical Oncology, MD Anderson Cancer Center, Houston, TX, USA. ^[1] Department of Surgical Oncology, Unit 1484, MD Anderson Cancer Center, Houston, TX, USA. ^[2] Departments of Biostatistics, MD Anderson Cancer Center, Houston, TX, USA. ^[3] Departments of Pathology, MD Anderson Cancer Center, Houston, TX, USA. ^[4] Departments of Radiation Oncology, MD Anderson Cancer Center, Houston, TX, USA. ^[5] Department of Surgical Oncology, Unit 1484, MD Anderson Cancer Center, Houston, TX, USA. bbadgwell@mdanderson.org. ^[6]

主题词腺癌(Adenocarcinoma);抗肿瘤联合化疗方案(Antineoplastic Combined Chemotherapy Protocols);贝叶斯定理(Bayes Theorem);顺铂(Cisplatin);综合疗法(Combined Modality Therapy);人类(Humans);高温, 诱发(Hyperthermia, Induced);丝裂霉素(Mitomycin);紫杉酚(Paclitaxel);灌流(Perfusion);腹膜肿瘤(Peritoneal Neoplasms);胃肿瘤(Stomach Neoplasms)

DOI 10.1245/s10434-020-08226-x

PMID 31974712

发布时间 2023-02-02

翻译满意度评价：

准确一般字义偏差语意偏离译文作用小提交

浏览6

Annals of surgical oncology

Annals of surgical oncology

2020年27卷8期

2806-2811页

相似文献

中文期刊
外文期刊
学位论文
会议论文

特别提示：本网站仅提供医学学术资源服务，不销售任何药品和器械，有关药品和器械的销售信息，请查阅其他网站。

客服热线：4000-115-888 转3 (周一至周五：8:00至17:00)
|
客服邮箱：yiyao@wanfangdata.com.cn

违法和不良信息举报电话：4000-115-888，举报邮箱：problem@wanfangdata.com.cn，举报专区

官方微信

万方医学小程序

关于我们网站地图知识产权

北京万方数据股份有限公司

万方数据电子出版社

京ICP证010071号

京公网安备11010802020237号

京ICP备08100800号-1

违法和不良信息举报电话：4000-115-888，举报邮箱：problem@wanfangdata.com.cn，举报专区

new翻译充值订阅收藏移动端

官方微信

万方医学小程序

调查问卷